Pathways Neuro Pharma Inc. Announces Strategic Focus on Rare Pediatric Diseases, Led by Juvenile Parkinson’s Disease
Pathways Neuro Pharma shifts focus to rare pediatric diseases, advancing a groundbreaking non-agonist gene therapy for Juvenile Parkinson’s Disease. WEST CHESTER, PA, UNITED STATES, February 27, 2025 /EINPresswire.com/ -- Pathways Neuro Pharma Inc., a …